Acinetobacter baumannii Infections in Times of COVID-19 Pandemic

K Rangel, TPG Chagas, SG De-Simone - Pathogens, 2021 - mdpi.com
The COVID-19 pandemic has generated an overuse of antimicrobials in critically ill patients.
Acinetobacter baumannii frequently causes nosocomial infections, particularly in intensive …

The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a …

R Thoma, M Seneghini, SN Seiffert… - … Resistance & Infection …, 2022 - Springer
Background Despite the adoption of strict infection prevention and control measures, many
hospitals have reported outbreaks of multidrug-resistant organisms (MDRO) during the …

Coinfections with other respiratory pathogens among patients with COVID-19

K Sreenath, P Batra, EV Vinayaraj, R Bhatia… - Microbiology …, 2021 - Am Soc Microbiol
Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2)-infected individuals are at an increased risk for coinfections; therefore, physicians …

Impact of SARS-CoV-2 epidemic on antimicrobial resistance: a literature review

FV Segala, DF Bavaro, F Di Gennaro, F Salvati… - Viruses, 2021 - mdpi.com
Antimicrobial resistance is an urgent threat to public health and global development; in this
scenario, the SARS-CoV2 pandemic has caused a major disruption of healthcare systems …

Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study

FLG Altamirano, X Kostoulias, D Subedi, D Korneev… - …, 2022 - thelancet.com
Background Clinical phage therapy is often delivered alongside antibiotics. However, the
phenomenon of phage-antibiotic synergy has been mostly studied in vitro. Here, we …

[HTML][HTML] The interface between COVID-19 and bacterial healthcare-associated infections

RF O'Toole - Clinical Microbiology and Infection, 2021 - Elsevier
Background A wide range of bacterial infections occur in coronavirus disease 2019 (COVID-
19) patients, particularly in those with severe coronaviral disease. Some of these are …

Emerging Concern for Silver Nanoparticle Resistance in Acinetobacter baumannii and Other Bacteria

O McNeilly, R Mann, M Hamidian… - Frontiers in …, 2021 - frontiersin.org
The misuse of antibiotics combined with a lack of newly developed ones is the main
contributors to the current antibiotic resistance crisis. There is a dire need for new and …

Trends in Pseudomonas aeruginosa (P. aeruginosa) Bacteremia during the COVID-19 Pandemic: A Systematic Review

QX Ng, NY Ong, DYX Lee, CE Yau, YL Lim, ALH Kwa… - Antibiotics, 2023 - mdpi.com
Pseudomonas aeruginosa (P. aeruginosa) is among the most common pathogens
associated with healthcare-acquired infections, and is often antibiotic resistant, causing …

Outbreak of endemic carbapenem-resistant Acinetobacter baumannii in a coronavirus disease 2019 (COVID-19)–specific intensive care unit

DR Shinohara, SM dos Santos Saalfeld… - Infection Control & …, 2022 - cambridge.org
2. Wee LE, Conceicao EP, Tan JY, et al. Unintended consequences of infection prevention
and control measures during COVID-19 pandemic. Am J Infect Control 2020. doi: 10.1016/j …

Acinetobacter baumannii Isolates from COVID-19 Patients in a Hospital Intensive Care Unit: Molecular Typing and Risk Factors

M Ceparano, V Baccolini, G Migliara, C Isonne… - Microorganisms, 2022 - mdpi.com
Infections caused by Acinetobacter baumannii represent a major concern for intensive care
unit (ICU) patients. However, the epidemiology of these infections among COVID-19 patients …